| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 10/29/2008 | CN101293833A 5-oxygen-substituted benzene alkene propionyl quinic acid compounds and medicine uses thereof |
| 10/29/2008 | CN101293830A 1-oxygen-[3-aryl substituted-alkene propionyl]quinic acid compounds and uses |
| 10/29/2008 | CN101293821A Compounds for inhibiting multi-medicine medicine-resistant staphylococcus aureus activity |
| 10/29/2008 | CN101293099A Polypeptide vaccine for resisting multiple hypotype avian influenza viruses and preparation method thereof |
| 10/29/2008 | CN101293098A Recombined cattle O type foot and mouth disease virus amalgamation protein vaccine |
| 10/29/2008 | CN101293089A Method for preparing phaescolosaxin oral administration dosage form |
| 10/29/2008 | CN101293083A Pharmaceutical composition and preparation method thereof |
| 10/29/2008 | CN101293053A Novel preparation method for donkey-hide gelatin hematonic and quality control method |
| 10/29/2008 | CN101293036A Compound essential oil for treating common cold, allergic rhinitis and pharyngitis, and preparation method thereof |
| 10/29/2008 | CN101293028A Medicament for treating hepatitis B |
| 10/29/2008 | CN101293012A Antiviral honeysuckle flower Chinese medicine compound preparation and preparation technique |
| 10/29/2008 | CN101293010A Myocarditis rehabilitation pill and preparation method thereof |
| 10/29/2008 | CN101293003A Effect section of frangrant ainsliaea herb, preparation method and application thereof |
| 10/29/2008 | CN101292995A Hypochlorous acid oxidized apply externally cleaning disinfection liquid |
| 10/29/2008 | CN101292985A Levofloxacin Lactate freeze-dried injection and preparation method thereof |
| 10/29/2008 | CN101292982A Enoxacin freeze-dried powder needle composing prescription and preparation technique |
| 10/29/2008 | CN101292733A Scentless healthy garlic powder (piece) nonhygroscopic agglomeration oxidation disintegration resistant preparation method |
| 10/29/2008 | CN100429313C Bacterial plasmids |
| 10/29/2008 | CN100429232C Vaughan Tristan J. |
| 10/29/2008 | CN100429210C Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents |
| 10/29/2008 | CN100428961C Artificial recombination selection replication type adenovirus and application |
| 10/29/2008 | CN100428959C Process for producing drug ultramicroparticle and apparatus therefor |
| 10/29/2008 | CN100428954C Vaginal effervescence tablet of interferon and its preparation method |
| 10/29/2008 | CN100428936C 抗病毒化合物 Antiviral compounds |
| 10/29/2008 | CN100428935C Abiduoer granular formulation |
| 10/29/2008 | CN100428930C Application of p-hydroxybenzoic acid and its analogue in the preparing process of medicine for preventing and treating skin mucous membrane virus infection |
| 10/29/2008 | CN100428925C Preparation of Herba Moslae extract and quality control thereof |
| 10/28/2008 | US7442790 Caspase inhibitors and uses thereof |
| 10/28/2008 | US7442713 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 10/28/2008 | US7442705 HIV replication inhibiting pyrimidines and triazines |
| 10/28/2008 | US7442704 Amide derivatives |
| 10/28/2008 | US7442703 Piperidine derivatives useful as CCR5 antagonists |
| 10/28/2008 | US7442699 For treatment of rheumatoid arthritis, inflammatory or autoimmune condition, viral infection, cancer; 4-{[4-(4-chlorophenyl)pyrimidin-2-yl]amino}benzamide |
| 10/28/2008 | US7442695 Depeptidized inhibitors of hepatitis C virus NS3 protease |
| 10/28/2008 | US7442683 For use as antifungal agent |
| 10/28/2008 | US7442547 Dendritic cells and the uses thereof in screening cellular targets and potential drugs |
| 10/28/2008 | US7442546 Method of modulating inflammatory response |
| 10/28/2008 | US7442524 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia |
| 10/28/2008 | US7442386 Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies |
| 10/28/2008 | US7442380 Treatment of diseases caused by viral infection |
| 10/28/2008 | US7442379 Recombinant Newcastle disease virus RNA expression systems and vaccines |
| 10/28/2008 | US7442378 Having mutation in viral nucleic acid encoding viral protein 2; bird and chicken vaccines |
| 10/28/2008 | US7442368 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation |
| 10/28/2008 | CA2472107C Dibenzodiazepine derivates, their preparation and use |
| 10/28/2008 | CA2442227C Ccr5 antagonists useful for treating aids |
| 10/28/2008 | CA2373868C Compositions comprising organosiloxane resins for delivering oral care substances |
| 10/28/2008 | CA2342102C Tan-1057 derivatives |
| 10/28/2008 | CA2331141C Water soluble azoles as broad-spectrum antifungals |
| 10/28/2008 | CA2300876C Naphthoquinone derivatives as hiv matrix protein tyrosine position 29 pocket binders |
| 10/28/2008 | CA2300319C 4-cyano-4-deformylsordaricin derivatives |
| 10/28/2008 | CA2262791C Amino acid ester containing azole antifungals |
| 10/28/2008 | CA2232222C Treatment of hiv positive patients |
| 10/28/2008 | CA2225924C Recombinant mistletoe lectin |
| 10/24/2008 | CA2587110A1 Least damaging treatments for antibiotic bacteria/viruses (& virulent strains) |
| 10/23/2008 | WO2008127300A2 Oxazolidinone derivatives and methods of use |
| 10/23/2008 | WO2008127275A2 Pyrrolinone compounds as inhibitors of bacterial peptidyl trna hydrolase and uses thereof |
| 10/23/2008 | WO2008127179A1 Fusion protein vaccine |
| 10/23/2008 | WO2008127099A1 Prevention of staphylococcus biofilm formation |
| 10/23/2008 | WO2008127060A1 Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza- spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same |
| 10/23/2008 | WO2008126782A1 Antiseptic agent for skin |
| 10/23/2008 | WO2008126034A2 Oxazolidinone antibiotics |
| 10/23/2008 | WO2008126024A2 Oxazolidinone antibiotic derivatives |
| 10/23/2008 | WO2008125985A2 Blocking interaction between pathogen factors and factor h to inhibit hemorrhagic syndromes |
| 10/23/2008 | WO2008125874A1 Benzofuran- carboxamide derivatives as antiviral agents |
| 10/23/2008 | WO2008125599A1 2-carboxy thiophene derivatives as anti-viral agents |
| 10/23/2008 | WO2008125594A1 Pyrrolo (3, 2, 1-ij) quinoline-4-one derivatives for treating tuberculosis |
| 10/23/2008 | WO2008125014A1 Urea compounds, preparation methods and pharmaceutical uses thereof |
| 10/23/2008 | WO2008124870A1 Delivery of flu antibodies to surfaces in contact with air |
| 10/23/2008 | WO2008097112B1 Amidinoanthracycline antibiotics for use in the treatment of viral infections |
| 10/23/2008 | WO2008064218A3 Amido anti-viral compounds |
| 10/23/2008 | WO2008047023A3 Immunisation method against the 4 dengue serotypes |
| 10/23/2008 | WO2008030853A3 Combination therapy for human immunodeficiency virus infection |
| 10/23/2008 | WO2007134245A3 Elastin-like polymer delivery vehicles |
| 10/23/2008 | WO2006118488A3 Processed sunflower black seed oil and use thereof in pharamac eut i cal and cosmetic compositions |
| 10/23/2008 | US20080262211 Hepatitis-c virus type 4, 5 and 6 |
| 10/23/2008 | US20080262204 A purified affinity-matured antibody or a portion thereof having binding specificity for 83 kDa protective antigen (PA83) of Bacillus anthracis; confers protection to a host against a tripartite toxin of Bacillus anthracis; cloned from an anti-Bacillus anthracis PA83 hybridoma |
| 10/23/2008 | US20080262097 Formulations |
| 10/23/2008 | US20080262082 S-(-)-tulipalin B, acetylated-S-(-)-tulipalin B and an antibacterial composition comprising the same. The active compound tulipalin B and composition of the present invention exhibit superior and stable antibacterial activity over a broad range of temperature and pH |
| 10/23/2008 | US20080262068 Method of Tonic Treatment With Oxyphenbutazone Derivatives |
| 10/23/2008 | US20080262058 Inhibitors of HCV replication of formula (I)** Image-1whereinW is a heterocycle of formula** Image-2and the remaining variables are as defined in the specification. |
| 10/23/2008 | US20080262056 (S) N-[3-(1-methyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide; staphylococci, streptococci, Enterococci, Haemophilus, Moraxella, bacteroides, clostridia, Mycobacteria, or Chlamydia |
| 10/23/2008 | US20080262040 novel indazole carboxamide derivatives for inflammatory and tissue repair disorders like rheumatoid arthritis, asthma, and COPD; kinase inhibitors in particular IKK2; 1,1-dimethylethyl-4-[4-(aminocarbonyl)-6-phenyl-1H-indazol-1-yl]-1-piperidinecarboxylate; intermediates |
| 10/23/2008 | US20080262039 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process For Making Them, and Use Thereof For Treating Pain and Other Conditions |
| 10/23/2008 | US20080262012 polymorphic forms alpha , beta and gamma; for the oral or topical route; In case of invasive bacteria, it may be useful to use the most bioavailable polymorphic form, whereas in case of non-invasive pathogens it may be more appropriate to use the less adsorbed forms, since they are safer |
| 10/23/2008 | US20080262007 replication inhibitors; improved ability to inhibit the replication of mutant strains, in particular strains which have become resistant to one or more known NNRTI drugs (Non Nucleoside Reverse Transcriptase Inhibitor drugs) |
| 10/23/2008 | US20080261986 Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug |
| 10/23/2008 | US20080261976 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 10/23/2008 | US20080261971 Novel Heterocyclic Nf-Kb Inhibitors |
| 10/23/2008 | US20080261964 Substituted quinolones II |
| 10/23/2008 | US20080261960 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 10/23/2008 | US20080261947 Poly(ADP-ribose)polymerase inhibitor; ischemic diseases, cerebral infarction, antiretroviral, sensitizer for anticancer therapy, immunosuppressant; 5,6,7,8-tetrahydrophthalazin-1(2H)-one compounds; 2,3,4,6-tetrahydropyrido[2,3-d]pyridazin-5(1H)-one compounds |
| 10/23/2008 | US20080261938 13-Cyclohexyl-5-(2-pyrrolidin-1-ylethoxy)-6,7-dihydro-5H-indolo[2.1-a][2]benzazepine-10-carboxylic acid, for example; use for the treatment or prevention of infection by hepatitis C virus |
| 10/23/2008 | US20080261906 Screen for agents that modulate replication of hepatitis C virus; detect binding modulators of TBC and NS5A, inhibition of TBC activity, inhibition of Rab1 activity, expression of the TBC protein and/or Rab1 protein |
| 10/23/2008 | US20080261900 Fluoroquinolones |
| 10/23/2008 | US20080261887 Administering porcine circovirus type 2 (PCV2) antigen, such as recombinant baculovirus expressed ORF2 antigen to a pig; lymphadenopathy, lymphoid depletion and/or multinucleated/giant histiocytes |
| 10/23/2008 | US20080261880 Synthetic approach to designed chemical structures |
| 10/23/2008 | US20080261877 Albumin Fusion Proteins |
| 10/23/2008 | US20080261869 For treating bacterial and viral infections; kits |
| 10/23/2008 | US20080261303 Method and medicament for inhibiting the expression of a given gene |
| 10/23/2008 | US20080261272 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity; DNA |